Biosimilar Education and Outreach
Forecast Overview
- NAICS
- 561499
- Performance end
- 4/2026
Continued contract support to deliver comprehensive, data-driven education and outreach initiatives and activities that improve awareness and understanding of biosimilars among patients, providers, and stakeholders.
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31